Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NRP1 | O14786 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807798 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRNRP1 | |
| SCHEMBL2807797 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRNRP1 | |
| SCHEMBL13128311 | 0.93 | L3MBTL1 (0.33) | — | |
| SCHEMBL2806461 | 0.85 | NRP1 (0.37) | NRP1 | |
| SCHEMBL2806462 | 0.85 | NRP1 (0.37) | NRP1 | |
| SCHEMBL2806465 | 0.85 | NRP1 (0.37) | NRP1 | |
| SCHEMBL2808807 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHRNRP1 | |
| SCHEMBL2808808 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHRNRP1 | |
| SCHEMBL13128313 | 0.79 | L3MBTL1 (0.36) | NRP1 | |
| SCHEMBL13128318 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240638-A1 | Organic Compounds and their uses | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240638-A1 | Organic Compounds and their uses | OAT, HAVCR2, CYP3A43 | ALDH1A1 302/4885TSHR 4756/4885NRP1 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.